The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Pantoflux 40 mg gastro-resistant tablets

40 milligram(s) Gastro-resistant tablet

Accord Healthcare Ireland Ltd.PA2315/187/002

Main Information

Trade NamePantoflux 40 mg gastro-resistant tablets
Active SubstancesPantoprazole sodium sesquihydrate
Strength40 milligram(s)
Dosage FormGastro-resistant tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/187/002

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC02 pantoprazole


Licence Issued09/06/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0013-004-005
Interchangeable List DocumentPDF of Interchangeable List
« Back